Avior Wealth Management LLC Has $4.69 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Avior Wealth Management LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,915 shares of the healthcare conglomerate’s stock after selling 162 shares during the period. Avior Wealth Management LLC’s holdings in UnitedHealth Group were worth $4,693,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in UNH. Axiom Financial Strategies LLC bought a new stake in shares of UnitedHealth Group in the first quarter valued at about $210,000. McGowan Group Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 8.9% in the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 31.8% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares in the last quarter. MAS Advisors LLC lifted its holdings in shares of UnitedHealth Group by 10.8% in the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after purchasing an additional 45 shares in the last quarter. Finally, First Western Trust Bank bought a new stake in UnitedHealth Group during the first quarter worth about $875,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH traded up $23.51 during trading hours on Tuesday, reaching $469.14. The stock had a trading volume of 11,815,185 shares, compared to its average volume of 4,407,902. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a market capitalization of $432.51 billion, a PE ratio of 19.66, a PEG ratio of 1.20 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company’s 50-day moving average is $491.15 and its two-hundred day moving average is $515.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.54 by $0.37. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the business posted $6.26 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Piper Sandler lowered their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Finally, Barclays assumed coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $573.80.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.